Question 1

What is HB1809?

Accepted Answer

HB1809 is a bill in the New Hampshire Legislature (2026 Regular Session): (New Title) establishing a medical psilocybin advisory board to assess the advantages and disadvantages of the use of psilocybin for therapeutic purposes.

Question 2

What does HB1809 do?

Accepted Answer

In its own words: An act establishing a medical psilocybin advisory board to assess the advantages and disadvantages of the use of psilocybin for therapeutic purposes. Rep. C. McGuire, Merr. 27; Rep. Layon, Rock. 13; Rep. Mandelbaum, Rock. 21; Rep. Sabourin dit Choiniere, Rock. 30; Sen. Fenton, Dist 10 COMMITTEE: Health, Human Services and Elderly Affairs ----------------------------------------------------------------- AMENDED ANALYSIS This bill establishes a medical psilocybin advisory board to assess the advantages and disadvantages of the use of psilocybin for therapeutic purposes. - - - - - - - - - - - - -.

Question 3

What is the status of HB1809?

Accepted Answer

Failed as of May 5, 2026. Latest action: Inexpedient to Legislate, MA, VV === BILL KILLED ===; 05/07/2026;  SJ 11 (May 5, 2026).

Question 4

Who sponsored HB1809?

Accepted Answer

Buzz Scherr (D, 26), with 5 co-sponsors.

Question 5

Where is the official record for HB1809?

Accepted Answer

On the New Hampshire Legislature website: https://gc.nh.gov/bill_status/legacy/bs2016/bill_docket_report.aspx?lsr=2497&sy=2026

New Hampshire HB1809: (New Title) establishing a medical psilocybin advisory board to assess the advantages and disadvantages of the use of psilocybin for therapeutic purposes.

What the bill says

Sponsors

Latest actions

Common questions